• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MET受体酪氨酸激酶在侵袭和转移中的作用

The MET receptor tyrosine kinase in invasion and metastasis.

作者信息

Benvenuti Silvia, Comoglio Paolo M

机构信息

Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Turin Medical School, Candiolo (Torino), Italy.

出版信息

J Cell Physiol. 2007 Nov;213(2):316-25. doi: 10.1002/jcp.21183.

DOI:10.1002/jcp.21183
PMID:17607709
Abstract

Various cytokines and soluble growth factors upon interaction with their membrane receptors are responsible for inducing cellular proliferation, differentiation, movement, and protection from anoikis (a planned suicide activated by normal cells in absence of attachment to neighboring cells or extracellular matrix (EMC)). Among those soluble factors a major position is exerted by hepatocyte growth factor (HGF) together with its receptor MET and macrophage-stimulating protein (MSP) in cooperation with its receptor RON.

摘要

各种细胞因子和可溶性生长因子与它们的膜受体相互作用后,负责诱导细胞增殖、分化、移动以及保护细胞免受失巢凋亡(一种由正常细胞在未附着于邻近细胞或细胞外基质(EMC)时激活的程序性自杀)。在这些可溶性因子中,肝细胞生长因子(HGF)与其受体MET以及巨噬细胞刺激蛋白(MSP)与其受体RON协同发挥主要作用。

相似文献

1
The MET receptor tyrosine kinase in invasion and metastasis.MET受体酪氨酸激酶在侵袭和转移中的作用
J Cell Physiol. 2007 Nov;213(2):316-25. doi: 10.1002/jcp.21183.
2
STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.STK/RON受体酪氨酸激酶通过HGF受体家族中保守的多功能对接位点介导凋亡信号和生长信号。
EMBO J. 1996 Nov 1;15(21):5866-75.
3
Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.原发性胰腺腺癌中 HGF/Met 和 MSP/Ron 系统的比较特征分析。
Cytokine. 2019 Nov;123:154762. doi: 10.1016/j.cyto.2019.154762. Epub 2019 Jun 26.
4
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.肝细胞生长因子和 c-Met 的共表达通过自分泌肝细胞生长因子/c-Met 信号预测胃癌腹膜转移的建立。
Int J Cancer. 2012 Jun 15;130(12):2912-21. doi: 10.1002/ijc.26330. Epub 2011 Sep 12.
5
Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats.在大鼠切除伤口修复过程中,肝细胞生长因子和巨噬细胞刺激蛋白上调。
Cell Tissue Res. 2001 Nov;306(2):239-50. doi: 10.1007/s004410100443.
6
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness.RON和MET癌基因在人类卵巢癌中共同表达,并协同激活侵袭性。
Exp Cell Res. 2003 Aug 15;288(2):382-9. doi: 10.1016/s0014-4827(03)00250-7.
7
Hepatocyte growth factor/MET in cancer progression and biomarker discovery.肝细胞生长因子/间质上皮转化因子在癌症进展及生物标志物发现中的作用
Cancer Sci. 2017 Mar;108(3):296-307. doi: 10.1111/cas.13156.
8
The scatter factor signaling pathways as therapeutic associated target in cancer treatment.分散因子信号通路作为癌症治疗中的治疗相关靶点。
Curr Med Chem. 2010;17(25):2699-712. doi: 10.2174/092986710791859261.
9
HGF/SF-met signaling in the control of branching morphogenesis and invasion.肝细胞生长因子/散射因子-间质表皮转化因子信号传导对分支形态发生和侵袭的调控
J Cell Biochem. 2003 Feb 1;88(2):408-17. doi: 10.1002/jcb.10358.
10
Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells.肝细胞生长因子和巨噬细胞刺激蛋白铰链区类似物在胰腺癌细胞中充当Met和Ron双抑制剂。
Anticancer Drugs. 2016 Sep;27(8):766-79. doi: 10.1097/CAD.0000000000000390.

引用本文的文献

1
The Construction of ceRNA Regulatory Network Unraveled Prognostic Biomarkers and Repositioned Drug Candidates for the Management of Pancreatic Ductal Adenocarcinoma.ceRNA调控网络的构建揭示了胰腺导管腺癌治疗的预后生物标志物和重新定位的候选药物。
Curr Issues Mol Biol. 2025 Jun 27;47(7):496. doi: 10.3390/cimb47070496.
2
Bioinformatics Analysis of Cancer Related CBP Mutations on Copper Ion and Drug Binding.癌症相关CBP突变对铜离子和药物结合的生物信息学分析
Protein J. 2025 Apr 29. doi: 10.1007/s10930-025-10266-9.
3
Prognostic analysis of anoikis-related genes in bladder cancer: An observational study.
膀胱癌中与失巢凋亡相关基因的预后分析:一项观察性研究。
Medicine (Baltimore). 2024 Jul 19;103(29):e38999. doi: 10.1097/MD.0000000000038999.
4
The Role of cMET in Gastric Cancer-A Review of the Literature.cMET在胃癌中的作用——文献综述
Cancers (Basel). 2023 Mar 26;15(7):1976. doi: 10.3390/cancers15071976.
5
Design, Synthesis, and Evaluation of New Mesenchymal-Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers.设计、合成与评价具有双手性中心的新型间质-上皮转化因子(c-Met)激酶抑制剂。
Molecules. 2022 Aug 23;27(17):5359. doi: 10.3390/molecules27175359.
6
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies.免疫疗法与分子靶向疗法联合治疗转移性黑色素瘤
Cancers (Basel). 2022 Aug 3;14(15):3779. doi: 10.3390/cancers14153779.
7
Progranulin A Promotes Compensatory Hepatocyte Proliferation via HGF/c-Met Signaling after Partial Hepatectomy in Zebrafish.颗粒蛋白前体 A 通过 HGF/c-Met 信号促进斑马鱼部分肝切除后的代偿性肝细胞增殖。
Int J Mol Sci. 2021 Oct 18;22(20):11217. doi: 10.3390/ijms222011217.
8
Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer.Smurfs的翻译后修饰:癌症中的新兴调控
Front Oncol. 2021 Feb 22;10:610663. doi: 10.3389/fonc.2020.610663. eCollection 2020.
9
Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗的晚期非小细胞肺癌患者血浆生物标志物的多重ELISA检测筛选
Cancers (Basel). 2020 Dec 31;13(1):97. doi: 10.3390/cancers13010097.
10
Mutant p53 on the Path to Metastasis.突变型p53在转移进程中的作用
Trends Cancer. 2020 Jan;6(1):62-73. doi: 10.1016/j.trecan.2019.11.004. Epub 2019 Dec 16.